Helping NET Cancer patients get a timely diagnosis,
the best care and ultimately a cure

If you don’t suspect it you can’t detect it

INCA - the global voice in support of neuroendocrine cancer patients

Information empowers patients to make decisions

Access to optimal treatment and care for all patients around the world

NET research needs more patient involvement and more resources

84% of NET patients
lack information


Their needs for information about treatment
options were not met at the time of diagnosis.

58% of NET patients are
diagnosed at an advanced stage

How Can I Help?

Latest News

Pheo Para Awareness Week – August 23-29

The Pheo Para Alliance launched the inaugural campaign to raise awareness for pheochromocytoma (pheo) and paraganglioma (para), rare neuroendocrine tumors, from August 23 – 29. The objectives of this week-long campaign were to inspire & empower pheo para constituents...

read more

HOOFING IT Across Canada for Neuroendocrine Cancer Research!

Between July 1st and September 7th, the Canadian neuroendocrine cancer community is working together in an effort to raise $100,000 in the 2020 Neuroendocrine cancer research fundraising campaign, HOOFING IT Across Canada for Neuroendocrine Cancer Research! After 45...

read more

AMEND Launches New PPGL GenNET Group

During the inaugural, international Phaeo Para Awareness Week (24-30 August), AMEND were delighted to launch a brand new group identity for patients and families in the UK affected by phaeochromocytoma and paraganglioma tumors and syndromes. Phaeo Para Support UK is...

read more